ABSTRACT
Allergic disease is caused by exposure to normally innocuous substances that activate mast cells. Mast cell-mediated allergic inflammation is closely related to a number of allergic disorders, such as anaphylaxis, allergic rhinitis, asthma and atopic dermatitis. The discovery of drugs for treating allergic disease is an interesting subject and important to human health. The aim of the present study was to investigate the antiallergic and anti-inflammatory effects of the aqueous extract of Pogostemon cablin (Blanco) Benth (AEPC) (a member of the Labiatae family) using mast cells, and also to determine its possible mechanisms of action. An intraperitoneal injection of compound 48/80 or a serial injection of immunoglobulin E and antigen was used to induce anaphylaxis in mice. We found that AEPC inhibited compound 48/80induced systemic and immunoglobulin E-mediated cutaneous anaphylaxis in a dose-dependent manner. The release of histamine from mast cells was reduced by AEPC, and this suppressive effect was associated with the regulation of calcium influx. In addition, AEPC attenuated the phorbol 12-myristate 13-acetate plus calcium ionophore A23187 (PMACI)-stimulated expression of pro-inflammatory cytokines in mast cells. The inhibitory effects of AEPC on pro-inflammatory cytokines were dependent on the activation of nuclear factor (NF)-κB and p38 mitogen-activated protein kinase (MAPK). AEPC blocked the PMACI-induced translocation of NF-κB into the nucleus by hindering the degradation of IκBα and the phosphorylation of p38 MAPK. Our results thus indicate that AEPC inhibits mast cellmediated allergic inflammation by suppressing mast cell degranulation and the expression of pro-inflammatory cytokines caused by reduced intracellular calcium levels and the activation of NF-κB and p38 MAPK.
Subject(s)
Anaphylaxis/drug therapy , Anti-Allergic Agents/therapeutic use , Anti-Inflammatory Agents/therapeutic use , Lamiaceae , Mast Cells/drug effects , Plant Extracts/therapeutic use , Anaphylaxis/chemically induced , Anaphylaxis/immunology , Animals , Anti-Allergic Agents/chemistry , Anti-Allergic Agents/pharmacology , Anti-Inflammatory Agents/chemistry , Anti-Inflammatory Agents/pharmacology , Calcium/immunology , Cell Degranulation/drug effects , Cells, Cultured , Cytokines/immunology , Lamiaceae/chemistry , Male , Mice, Inbred ICR , NF-kappa B/immunology , Passive Cutaneous Anaphylaxis/drug effects , Plant Extracts/chemistry , Plant Extracts/pharmacology , Rats, Sprague-Dawley , p-Methoxy-N-methylphenethylamine , p38 Mitogen-Activated Protein Kinases/immunologyABSTRACT
The objective of this study was to investigate the response of light emitting diodes (LEDs) at different light intensities (70 and 80 for green LEDs, 88 and 238 for red LEDs and 80 and 238 µmol m-2 s-1 for blue LEDs) at three wavelengths in lettuce leaves. Lettuce leaves were exposed to (522 nm), red (639 nm) and blue (470 nm) LEDs of different light intensities. Thylakoid multiprotein complex proteins and photosynthetic metabolism were then investigated. Biomass and photosynthetic parameters increased with an increasing light intensity under blue LED illumination and decreased when illuminated with red and green LEDs with decreased light intensity. The expression of multiprotein complex proteins including PSII-core dimer and PSII-core monomer using blue LEDs illumination was higher at higher light intensity (238 µmol m-2 s-1) and was lowered with decreased light intensity (70-80 µmol m-2 s-1). The responses of chloroplast sub-compartment proteins, including those active in stomatal opening and closing, and leaf physiological responses at different light intensities, indicated induced growth enhancement upon illumination with blue LEDs. High intensity blue LEDs promote plant growth by controlling the integrity of chloroplast proteins that optimize photosynthetic performance in the natural environment.
Subject(s)
Lactuca/radiation effects , Light , Multiprotein Complexes/metabolism , Photosynthesis/physiology , Plant Leaves/radiation effects , Dose-Response Relationship, Radiation , Electrophoresis, Polyacrylamide Gel , Hydrostatic Pressure , Lactuca/metabolism , Lactuca/physiology , Plant Leaves/metabolism , Plant Leaves/physiology , Plant Stomata/physiology , Plant Transpiration/physiology , Ribulose-Bisphosphate Carboxylase/metabolism , Semiconductors , Thylakoids/metabolism , Thylakoids/physiology , Thylakoids/radiation effects , Water/metabolism , Water/physiologyABSTRACT
In this study, we investigated the effect of a water extract of the ripe fruits of Rubus coreanus Miq. (Rosaceae) (RFRC) on mast cell-mediated allergic inflammation and studied the possible mechanism of action. Mast cell-mediated allergic disease is involved in many diseases such as anaphylaxis, rhinitis, asthma and atopic dermatitis. RFRC dose-dependently inhibited compound 48/80-induced systemic anaphylaxis and serum histamine release in mice. RFRC reduced the immunoglobulin E (IgE)-mediated local allergic reaction, passive cutaneous anaphylaxis. RFRC attenuated histamine release from rat peritoneal mast cells and human mast cells by the reduction of intracellular calcium. RFRC decreased the phorbol 12-myristate 13-acetate (PMA) and the calcium ionophore A23187 (PMACI)-stimulated expression and secretion of pro-inflammatory cytokines in human mast cells. The inhibitory effect of RFRC on cytokine production was nuclear factor (NF)-κB- and mitogen-activated protein kinase (MAPK)-dependent. In addition, RFRC suppressed the activation of caspase-1. Our findings provide evidence that RFRC inhibits mast cell-derived allergic inflammatory reactions, and for the involvement of calcium, NF-κB, MAPKs and caspase-1 in these effects. Furthermore, in vivo and in vitro anti-allergic inflammatory effects of RFRC provide affirmative proof of a possible therapeutic application of this agent in allergic inflammatory diseases.
Subject(s)
Anaphylaxis/immunology , Fruit/chemistry , Mast Cells/drug effects , Mast Cells/immunology , Plant Extracts/pharmacology , Rosaceae/chemistry , Anaphylaxis/chemically induced , Animals , Calcium/metabolism , Caspase 1/metabolism , Cell Line , Disease Models, Animal , Enzyme Activation/drug effects , Gene Expression/drug effects , Histamine Release/drug effects , Humans , Inflammation/immunology , Inflammation Mediators/metabolism , Male , Mice , Mitogen-Activated Protein Kinases/metabolism , NF-kappa B/metabolism , Rats , Rats, Sprague-Dawley , p-Methoxy-N-methylphenethylamine/adverse effectsABSTRACT
The methanolic extract of the roots of Polygonum multiflorum (Polygonaceae) was found to show inhibitory activity towards farnesyl protein transferase (FPTase). Bioassay-guided fractionation of the methanolic extract resulted in the isolation of two anthraquinone glycosides, as inhibitors of FPTase. These compounds inhibited the FPTase activity in a dose-dependent manner.
Subject(s)
Alkyl and Aryl Transferases/antagonists & inhibitors , Anthraquinones/pharmacology , Enzyme Inhibitors/pharmacology , Glycosides/pharmacology , Polygonum , Anthraquinones/chemistry , Anthraquinones/isolation & purification , Biological Assay , Chemical Fractionation , Dose-Response Relationship, Drug , Enzyme Inhibitors/chemistry , Enzyme Inhibitors/isolation & purification , Glycosides/chemistry , Glycosides/isolation & purification , Methanol/chemistry , Molecular Structure , Plant Roots , Polygonum/chemistry , Solvents/chemistryABSTRACT
The effect of an aqueous extract of Phlomis umbrosa Turcz. (Labiatae) root (PUAE) on mast cell-dependent allergic reactions and inflammatory cytokine secretion were investigated. PUAE (0.01-1 g/kg) inhibited compound 48/80-induced systemic allergic reaction. When PUAE was employed in a systemic allergic reaction test, the plasma histamine levels were reduced in a dose-dependent manner. PUAE (0.1 and 1 g/kg) also significantly inhibited the local allergic reaction activated by anti-dinitrophenyl (DNP) IgE. PUAE (0.001-1 mg/mL) dose-dependently inhibited the histamine release from rat peritoneal mast cells activated by compound 48/80 or anti-DNP IgE. PUAE (0.01-1 mg/mL) inhibited the secretion of interleukin (IL)-1beta in phorbol 12-myristate 13-acetate plus calcium ionophore A23187-stimulated human mast cell line (HMC-1) cells. PUAE (1 mg/mL) inhibited the gene expression and production of the main inflammatory cytokine, TNF-alpha, in HMC-1 cells. These results provide evidence that PUAE may be beneficial in the treatment of allergic diseases.
Subject(s)
Cytokines/metabolism , Hypersensitivity/prevention & control , Mast Cells/drug effects , Phlomis/chemistry , Plant Extracts/pharmacology , Plant Roots/chemistry , Animals , Blotting, Western , Cell Line , Cytokines/genetics , Enzyme-Linked Immunosorbent Assay , Gene Expression/drug effects , Histamine Release/drug effects , Humans , Hypersensitivity/immunology , Inflammation Mediators/metabolism , Interleukin-1beta/metabolism , Male , Mast Cells/metabolism , Mast Cells/pathology , Mice , Mice, Inbred ICR , Plant Extracts/chemistry , Rats , Rats, Sprague-Dawley , Reverse Transcriptase Polymerase Chain Reaction , Tumor Necrosis Factor-alpha/genetics , Tumor Necrosis Factor-alpha/metabolism , p-Methoxy-N-methylphenethylamine/pharmacologyABSTRACT
In this study, we investigated the effect of aqueous extract of Prunella vulgaris (Labiatae; PVAE) on the mast cell-mediated allergy model. We found that PVAE (0.001-0.1 g/kg) dose dependently inhibited compound 48/80-induced systemic anaphylaxis and serum histamine release in mice. PVAE decreased the IgE-mediated local allergic reaction, passive cutaneous anaphylaxis. In addition, PVAE attenuated phorbol 12-myristate 13-acetate (PMA) and calcium ionophore A23187-stimulated TNF-alpha, IL-6, and IL-8 secretion in human mast cells. The inhibitory effect of PVAE on proinflammatory cytokines was nuclear factor-kappaB (NF-kappaB) dependent. PVAE suppressed PMA and A23187-induced NF-kappaB/DNA binding activity and NF-kappaB-dependent gene reporter assay. Our findings provide evidence that PVAE inhibits mast cell-derived immediate-type allergic reactions and involvement of proinflammatory cytokines and NF-kappaB in these effects.
Subject(s)
Cytokines/metabolism , Hypersensitivity/metabolism , Mast Cells/metabolism , Plant Extracts/pharmacology , Prunella/metabolism , Animals , Histamine/metabolism , Inflammation , Ionophores/pharmacology , Male , Mast Cells/immunology , Mice , Mice, Inbred ICR , NF-kappa B/metabolism , Tetradecanoylphorbol Acetate , Tumor Necrosis Factor-alpha/metabolismABSTRACT
The immediate-type allergic reaction is involved in many allergic diseases such as asthma and allergic rhinitis. The discovery of drugs for the treatment of immediate-type allergic diseases is a very important subject in human health. In this study, we investigated the effect of Artemisia iwayomogi (AIAE) on mast cell-mediated allergic reaction and inflammatory cytokine secretion. AIAE inhibited compound 48/80-induced systemic reactions in mice. AIAE decreased the passive cutaneous anaphylaxis (PCA) reaction activated by antidinitrophenyl (anti-DNP) IgE antibody. AIAE dose-dependently reduced histamine release from rat peritoneal mast cells activated by compound 48/80 or anti-DNP IgE. Furthermore, AIAE attenuated the phorbol 12-myristate 13-acetate plus calcium ionophore A23187-stimulated tumor necrosis factor-alpha and interleukin-6 secretion in human mast cells. These results provide evidence that AIAE may be beneficial in the treatment of allergic diseases.
Subject(s)
Artemisia/chemistry , Cytokines/metabolism , Hypersensitivity, Immediate/prevention & control , Plant Extracts/pharmacology , Animals , Calcimycin/pharmacology , Cell Line, Tumor , Histamine Release/drug effects , Humans , Hypersensitivity, Immediate/chemically induced , Hypersensitivity, Immediate/metabolism , Immunoglobulin E/administration & dosage , Immunoglobulin E/immunology , Male , Mast Cells/cytology , Mast Cells/drug effects , Mast Cells/metabolism , Mice , Mice, Inbred ICR , Plant Extracts/chemistry , Plant Extracts/isolation & purification , Plant Leaves/chemistry , Rats , Rats, Sprague-Dawley , Tetradecanoylphorbol Acetate/pharmacology , Tumor Necrosis Factor-alpha/metabolism , p-Methoxy-N-methylphenethylamine/administration & dosage , p-Methoxy-N-methylphenethylamine/toxicityABSTRACT
Lupus-like syndrome is characterized by multiple organ injuries including lungs and kidneys. Endotoxin induces a transiently intent systemic inflammatory response and indirectly transient acute lung injury in normal condition. However, whether endotoxin may trigger the persistent development of lung injury in chronic, inflammatory lupus-like syndrome compared with normal condition remains unclear. We examined the pulmonary vascular permeability and production of proinflammatory cytokines, such as TNF-alpha, IL-6, IL-10 and IFN-gamma, which play prominent roles in the pathogenesis of lupus-like tissue injury, 6 h and 72 h after i.p. lipopolysaccharide (LPS; endotoxin) injection in pristane-primed chronic inflammation ICR mice characterized by a lupus-like syndrome. These results demonstrated that levels of serum IL-6, IL-10 and IFN-gamma and bronchoalveolar lavage (BAL) IL-6 and IFN-gamma were remarkably increased 6 h in LPS-exposed pristane-primed mice compared with pristane-primed controls, while pulmonary vascular permeability and levels of serum and BAL TNF-alpha were not. And levels of BAL TNF-alpha, IL-6 and IL-10 were significantly enhanced 72 h in LPS-exposed pristane-primed mice compared with pristane-primed controls. Also, LPS significantly induced the increased in vitro production of TNF-alpha, IL-6 and IL-10 by lung cells obtained from LPS-exposed pristane-primed mice compared with LPS-exposed normal mice. Our findings indicate that LPS may trigger persistent progression of lung injury through late overproduction of BAL TNF-alpha, IL-6, and IL-10 in lupus-like chronic inflammation syndrome compared with normal condition.
Subject(s)
Cytokines/biosynthesis , Lupus Erythematosus, Systemic/metabolism , Animals , Bronchoalveolar Lavage Fluid/chemistry , Capillary Permeability , Cells, Cultured , Cytokines/blood , Disease Models, Animal , Endotoxins , Female , Interleukin-10/biosynthesis , Interleukin-10/blood , Interleukin-6/biosynthesis , Interleukin-6/blood , Lipopolysaccharides , Lung/blood supply , Lung/metabolism , Lupus Erythematosus, Systemic/blood , Lupus Erythematosus, Systemic/chemically induced , Mice , Mice, Inbred ICR , Terpenes , Time Factors , Tumor Necrosis Factor-alpha/biosynthesisABSTRACT
The immediate-type allergic reaction (anaphylaxis) is involved in many allergic diseases such as asthma, allergic rhinitis and sinusitis. We investigated the effect of the gall of Rhus javanica (GRJ) on the model of the immediate-type allergic reaction, and studied its possible mechanisms. GRJ inhibited compound 48/80-induced systemic reactions in mice. GRJ attenuated immunoglobulin (Ig) E-mediated local allergic reactions. In addition, GRJ dose dependently decreased histamine release from rat peritoneal mast cells activated by compound 48/80 or IgE. The decreasing effect of GRJ on the histamine release was mediated by the modulation of cAMP and [Ca2+]i in mast cells. Furthermore, GRJ decreased the phorbol 12-myristate 13-acetate plus calcium ionophore A23187-stimulated TNF-alpha and IL-6 secretion in human mast cells. The inhibitory effect of GRJ on the pro-inflammatory cytokine was c-Jun N-terminal kinase and nuclear factor-kappaB dependent. Our findings provide evidence that GRJ inhibits mast cell-derived immediate-type allergic reactions, and suggest the possible mechanisms of action.